0001213900-24-020087.txt : 20240305 0001213900-24-020087.hdr.sgml : 20240305 20240305152038 ACCESSION NUMBER: 0001213900-24-020087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HSU ERIC C CENTRAL INDEX KEY: 0001817867 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 24719912 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2024-03-04 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817867 HSU ERIC C C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 Sr. VP, Pre-Clinical Res/Dev 0 Employee Stock Option (Expiration) 364.72 2024-03-04 4 H 0 309 0.00 D 2019-03-04 2024-03-04 Common shares 309 52545 D Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00 /s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu 2024-03-05